Cancer Risk in Relatives of Testicular Cancer Patients by Histology Type and Age at Diagnosis: A Joint Study from Five Nordic Countries.

[1]  J. Lortet-Tieulent,et al.  Testicular cancer incidence to rise by 25% by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data. , 2014, European journal of cancer.

[2]  Odd O Aalen,et al.  A hierarchical frailty model for familial testicular germ-cell tumors. , 2014, American journal of epidemiology.

[3]  Z. Cai,et al.  Telomerase reverse transcriptase gene promoter mutations help discern the origin of urogenital tumors: a genomic and molecular study. , 2014, European urology.

[4]  L. Looijenga.  Testicular germ cell tumors. , 2014, Pediatric endocrinology reviews : PER.

[5]  H. Zeeb,et al.  Testicular cancer and viral infections: A systematic literature review and meta‐analysis , 2013, Journal of medical virology.

[6]  B. Nixon,et al.  The rise of testicular germ cell tumours: the search for causes, risk factors and novel therapeutic targets , 2013, F1000Research.

[7]  K. Hemminki,et al.  Familial risk of early and late onset cancer: nationwide prospective cohort study , 2012, BMJ : British Medical Journal.

[8]  R. Carachi,et al.  A meta-analysis of the risk of boys with isolated cryptorchidism developing testicular cancer in later life , 2012, Archives of Disease in Childhood.

[9]  F. Bray,et al.  Thirty year trends in testicular cancer mortality in Europe: Gaps persist between the East and West , 2012, Acta oncologica.

[10]  K. McGlynn,et al.  Adolescent and adult risk factors for testicular cancer , 2012, Nature Reviews Urology.

[11]  M. Greene,et al.  Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype. , 2010, Endocrine-related cancer.

[12]  Jan Sundquist,et al.  The Swedish Family‐Cancer Database 2009: prospects for histology‐specific and immigrant studies , 2010, International journal of cancer.

[13]  Mark P Purdue,et al.  International Trends in the Incidence of Testicular Cancer, 1973-2002 , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[14]  Jacques Ferlay,et al.  NORDCAN – a Nordic tool for cancer information, planning, quality control and research , 2010, Acta oncologica.

[15]  Bingshu E. Chen,et al.  Younger age-at-diagnosis for familial malignant testicular germ cell tumor , 2009, Familial Cancer.

[16]  R. Motzer,et al.  Medical treatment of advanced testicular cancer. , 2008, JAMA.

[17]  H. Adami,et al.  Testicular cancer incidence in eight northern European countries: secular and recent trends. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[18]  K. Hemminki,et al.  Familial risk in testicular cancer as a clue to a heritable and environmental aetiology , 2004, British Journal of Cancer.

[19]  K. Czene,et al.  Familial risk of urological cancers: data for clinical counseling , 2004, World Journal of Urology.

[20]  K. Hemminki,et al.  Familial testicular cancer and second primary cancers in testicular cancer patients by histological type. , 2001, European journal of cancer.

[21]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1997 .

[22]  J. Olsen,et al.  Cancer risk in fathers and brothers of testicular cancer patients in Denmark. A population‐based study , 1996, International journal of cancer.

[23]  K. Heimdal,et al.  Familial testicular cancer in Norway and southern Sweden. , 1996, British Journal of Cancer.

[24]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[25]  K. Czene,et al.  Familial risk of cancer: Data for clinical counseling and cancer genetics , 2004 .

[26]  K. Heimdal,et al.  A segregation analysis of testicular cancer based on Norwegian and Swedish families. , 1997, British Journal of Cancer.